A Proof of Concept, Phase 1 Study of CGB-600 for the Topical Treatment of Non-Segmented Facial Vitiligo

NCT07357870 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Vitiligo

Interventions

DRUG: Drug: CGB-600 gel, experimental drug
OTHER: placebo: gel vehicle

Sponsor

CAGE Bio Inc.